4.6 Article

Race, Ethnicity, Psychosocial Factors, and Telomere Length in a Multicenter Setting

Journal

PLOS ONE
Volume 11, Issue 1, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0146723

Keywords

-

Funding

  1. National Institutes of Health [P50-CA105641, P60-NM006900, R01-CA85074, F31-AG039986]

Ask authors/readers for more resources

Background Leukocyte telomere length(LTL) has been associated with age, self-reported race/ethnicity, gender, education, and psychosocial factors, including perceived stress, and depression. However, inconsistencies in associations of LTL with disease and other phenotypes exist across studies. Population characteristics, including race/ethnicity, laboratory methods, and statistical approaches in LTL have not been comprehensively studied and could explain inconsistent LTL associations. Methods LTL was measured using Southern Blot in 1510 participants from a multi-ethnic, multi-center study combining data from 3 centers with different population characteristics and laboratory processing methods. Main associations between LTL and psychosocial factors and LTL and race/ethnicity were evaluated and then compared across generalized estimating equations(GEE) and linear regression models. Statistical models were adjusted for factors typically associated with LTL(age, gender, cancer status) and also accounted for factors related to center differences, including laboratory methods(i.e., DNA extraction). Associations between LTL and psychosocial factors were also evaluated within race/ethnicity subgroups (Non-hispanic Whites, African Americans, and Hispanics). Results Beyond adjustment for age, gender, and cancer status, additional adjustments for DNA extraction and clustering by center were needed given their effects on LTL measurements. In adjusted GEE models, longer LTL was associated with African American race (Beta(beta) (standard error(SE)) = 0.09(0.04), p-value = 0.04) and Hispanic ethnicity (beta(SE) = 0.06 (0.01), p-value = 0.02) compared to Non-Hispanic Whites. Longer LTL was also associated with less than a high school education compared to having greater than a high school education (a(SE) = 0.06(0.02), p-value = 0.04). LTL was inversely related to perceived stress (a (SE) = -0.02(0.003), p < 0.001). In subgroup analyses, there was a negative association with LTL in African Americans with a high school education versus those with greater than a high school education(beta(SE) = -0.11(0.03), p-value < 0.001). Conclusions Laboratory methods and population characteristics that differ by center can influence telomere length associations in multicenter settings, but these effects could be addressed through statistical adjustments. Proper evaluation of potential sources of bias can allow for combined multicenter analyses and may resolve some inconsistencies in reporting of LTL associations. Further, biologic effects on LTL may differ under certain psychosocial and racial/ethnic circumstances and could impact future health disparity studies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Meeting Abstract Oncology

Temporal changes in the screening, diagnosis and surgical treatment of genitourinary (GU) malignancies during the COVID-19 pandemic.

Chris Labaki, Andrew Lachlan Schmidt, Ziad Bakouny, Muhieddine Labban, Talal El Zarif, Steven Lee Chang, Bradley Alexander McGregor, Adam S. Kibel, Timothy Rebbeck, Quoc-Dien Trinh, Toni K. Choueiri

JOURNAL OF CLINICAL ONCOLOGY (2022)

Article Oncology

Gaps in completion and timeliness of breast surgery and adjuvant therapy: a retrospective cohort of Haitian patients with nonmetastatic breast cancer

Temidayo A. Fadelu, Parsa Erfani, Joarly Lormil, Ruth Damuse, Viergela Pierre, Sarah Slater, Scott A. Triedman, Lawrence N. Shulman, Timothy R. Rebbeck

Summary: This study analyzed treatment data of 312 female patients with non-metastatic breast cancer in Haiti and found that 80% of patients completed breast surgery, but nearly half experienced delays in surgery and adjuvant chemotherapy initiation. The study did not find an association between surgical delays and disease-free survival.

BREAST CANCER RESEARCH AND TREATMENT (2022)

Review Oncology

Multicancer Early Detection Technologies: A Review Informed by Past Cancer Screening Studies

Sana Raoof, Richard J. Lee, Kunal Jajoo, Joseph D. Mancias, Timothy R. Rebbeck, Steven J. Skates

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2022)

Article Oncology

Racial Disparities in Prostate Cancer: Evaluation of Diet, Lifestyle, Family History, and Screening Patterns

Megan Hansen, Nadine M. Hamieh, Sarah C. Markt, Jane B. Vaselkiv, Claire H. Pernar, Amparo G. Gonzalez-Feliciano, Samuel Peisch, Ilkania M. Chowdhury-Paulino, Emily M. Rencsok, Timothy R. Rebbeck, Elizabeth A. Platz, Edward L. Giovannucci, Kathryn M. Wilson, Lorelei A. Mucci

Summary: In the Health Professionals Follow-up Study (HPFS), African American men have a higher risk of prostate cancer and higher mortality rates compared to White men. Asian American men have a lower risk of prostate cancer, but similar risk of fatal disease compared to White men. Racial disparities in prostate cancer incidence and mortality cannot be fully explained by differences in lifestyle, diet, family history, or PSA screening.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2022)

Editorial Material Biochemistry & Molecular Biology

The distinct impacts of race and genetic ancestry on health COMMENT

Timothy R. Rebbeck, Brandon Mahal, Kara N. Maxwell, Isla P. Garraway, Kosj Yamoah

Summary: Genetic ancestry has an impact on human health, but it differs from the influence of race, which is a social construct rooted in systemic racism. Better defining and understanding these terms in medical research is crucial for achieving health equity.

NATURE MEDICINE (2022)

Article Endocrinology & Metabolism

Current and projected number of years of life lost due to prostate cancer: A global study

Diana Withrow, Sophie Pilleron, Nikita Nikita, Jacques Ferlay, Swapnil Sharma, Brian Nicholson, Timothy R. Rebbeck, Grace Lu-Yao

Summary: There is significant variation in the burden of prostate cancer globally, as measured by YLL. The burden of prostate cancer is projected to increase over time, with the highest burden expected in Sub-Saharan Africa, Eastern Europe, and Latin America and the Caribbean. Planning and implementing programs to reduce the burden of prostate cancer globally will be critical.

PROSTATE (2022)

Article Oncology

Substantial Gleason reclassification in Black men with national comprehensive cancer network low-risk prostate cancer - A propensity score analysis

Shivanshu Awasthi, Brandon A. Mahal, Jong Y. Park, Jordan H. Creed, Vonetta L. Williams, Asmaa Elkenawi, Sylvester O. Meadows, Julio M. Pow-Sang, Grace Lu-Yao, Wm. Kevin Kelly, Damaris-Lois Y. Lang, Janice Zgibor, Timothy R. Rebbeck, Kosj Yamoah

Summary: Evidence suggests that Black men with low-risk prostate cancer may have a higher risk of Gleason score reclassification compared to White men, particularly in extreme reclassification. Additionally, the time to treatment can non-linearly impact Gleason reclassification in Black men.

PROSTATE CANCER AND PROSTATIC DISEASES (2022)

Review Multidisciplinary Sciences

Early detection of cancer

David Crosby, Sangeeta Bhatia, Kevin M. Brindle, Lisa M. Coussens, Caroline Dive, Mark Emberton, Sadik Esener, Rebecca C. Fitzgerald, Sanjiv S. Gambhir, Peter Kuhn, Timothy R. Rebbeck, Shankar Balasubramanian

Summary: Early detection of cancer is crucial for improving survival rates, but unfortunately, a significant number of cases are diagnosed at an advanced stage. Overcoming various challenges is essential to achieve early detection for all cancers, including understanding high-risk individuals, elucidating the biology and trajectory of precancer and early cancer, and developing sensitive and specific detection technologies.

SCIENCE (2022)

Article Medicine, General & Internal

Retrospective analysis to describe trends in first-ever prostate-specific antigen (PSA) testing for primary healthcare facilities in the Gauteng Province, South Africa, between 2006 and 2016

Naseem Cassim, Timothy R. Rebbeck, Deborah K. Glencross, Jaya A. George

Summary: The study used laboratory data to describe PSA testing trends for PHC services in a single province, finding a significant increase in the number of men tested from 2006 to 2016, with the majority of tests being conducted for men in the 50-59 age category and Black Africans. PSA levels increased with age, and the proportion of men with PSA >= 4 mu g/L increased with age, with significant differences in the probability of having PSA >= 4 mu g/L among different racial groups.

BMJ OPEN (2022)

Article Oncology

Race-specific prostate cancer outcomes in a cohort of military health care beneficiaries undergoing surgery: 1990-2017

Nathan Oehrlein, Samantha A. Streicher, Huai-Ching Kuo, Avinash Chaurasia, Jacob McFadden, Darryl Nousome, Yongmei Chen, Sean P. Stroup, John Musser, Timothy Brand, Christopher Porter, Inger L. Rosner, Gregory T. Chesnut, Kayla C. Onofaro, Timothy R. Rebbeck, Anthony D'Amico, Grace Lu-Yao, Jennifer Cullen

Summary: This study found that African American patients had a shorter survival time after prostate cancer treatment, but no significant difference was observed between African American and Caucasian American patients in the time from biochemical recurrence to metastasis and metastasis to overall death in an equal access healthcare setting.

CANCER MEDICINE (2022)

Article Oncology

The tumor mutational landscape of BRCA2-deficient primary and metastatic prostate cancer

Kevin H. Kensler, Shakuntala Baichoo, Shailja Pathania, Timothy R. Rebbeck

Summary: Carriers of germline BRCA2 pathogenic sequence variants have an increased risk of aggressive prostate cancer, and may benefit from precision oncology treatments. This study found distinct genomic alterations between BRCA2-deficient (BRCA2(d)) and BRCA2-intact (BRCA2(i)) prostate tumors, which are associated with etiological and prognostic differences.

NPJ PRECISION ONCOLOGY (2022)

Article Oncology

Prostate Cancer Screening, Diagnostic, Treatment Procedures and Costs in Sub-Saharan Africa: A Situational Analysis

Louise K. Makau-Barasa, Achille Manirakiza, Andre L. Carvalho, Timothy R. Rebbeck

Summary: Prostate cancer mortality is predicted to increase in Sub-Saharan Africa due to the lack of screening and late-stage diagnosis. This study examined the availability and use of screening, diagnostic, and treatment guidelines for prostate cancer in SSA countries. The findings suggest that PSA and DRE exams are available for early detection, but there are concerns about overdiagnosis and overtreatment. National policies should consider multiple factors to ensure access to relevant and safe care.

CANCER CONTROL (2022)

Article Urology & Nephrology

Variation in Molecularly Defined Prostate Tumor Subtypes by Self-identified Race

Kevin H. Kensler, Shivanshu Awasthi, Mohamed Alshalalfa, Bruce J. Trock, Stephen J. Freedland, Michael R. Freeman, Sungyong You, Brandon A. Mahal, Robert B. Den, Adam P. Dicker, R. Jeffrey Karnes, Eric A. Klein, Priti Lal, Yang Liu, Elai Davicioni, Walter Rayford, Kosj Yamoah, Timothy R. Rebbeck

Summary: This study investigates the impact of self-identified race on prostate cancer subtypes and genomic aggressiveness. The results show that specific subtypes are more common among Black men, while other subtypes are more common among White men.

EUROPEAN UROLOGY OPEN SCIENCE (2022)

Meeting Abstract Medicine, Research & Experimental

Grading of Prostate Cancer in Africa Using Whole Slide Imaging: Interobserver Variation among Pathologists and Artificial Intelligence

Abraham van Wyk, Timothy Rebbeck, Brian Robinson, Olufemi Ogunbiyi, Olabode Oluwole, Lynnette Kyokunda, Cherif Dial, Afua Abrahams, Frederick Hobenu, Sun Woo Kim, Massimo Loda, Priti Lal

LABORATORY INVESTIGATION (2022)

Meeting Abstract Pathology

Grading of Prostate Cancer in Africa Using Whole Slide Imaging: Interobserver Variation among Pathologists and Artificial Intelligence

Abraham van Wyk, Timothy Rebbeck, Brian Robinson, Olufemi Ogunbiyi, Olabode Oluwole, Lynnette Kyokunda, Cherif Dial, Afua Abrahams, Frederick Hobenu, Sun Woo Kim, Massimo Loda, Priti Lal

MODERN PATHOLOGY (2022)

No Data Available